Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP620848.RARWW1Svk6y_TNvzMamrjQHQHfFoQL1a0ySaqCM6z-zvI130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620848.RARWW1Svk6y_TNvzMamrjQHQHfFoQL1a0ySaqCM6z-zvI130_provenance.
• NP623601.RAZn-d6vHrBXsD_GYNRwURGC6hiO8DhgS7FG2hZh4Nc0w130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623601.RAZn-d6vHrBXsD_GYNRwURGC6hiO8DhgS7FG2hZh4Nc0w130_provenance.
• assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1147106.RAV5mrHm0ulEDBe8KkwO7fQQJz0Sq1MSYcwnu639dnjEQ130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147106.RAV5mrHm0ulEDBe8KkwO7fQQJz0Sq1MSYcwnu639dnjEQ130_provenance.
• NP622286.RAkZi5GHbmyhkDYqlLX4k7aOro1etGfbntqJP27YWfZt8130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622286.RAkZi5GHbmyhkDYqlLX4k7aOro1etGfbntqJP27YWfZt8130_provenance.
• NP1147104.RAj-YLHE90rDMVYKwAAcQmxRFPppTB6aAvh1SsEwPRfos130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147104.RAj-YLHE90rDMVYKwAAcQmxRFPppTB6aAvh1SsEwPRfos130_provenance.
• NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231922.RAxt7ERr43HrIEjZfOUo-0Tug7Qds-2ABAyAr94RyJVLc130_provenance.
• NP624729.RA6ydFzsLQnZcoU7Fuiighs-R6VFzyesTC9gC5BUMdr9w130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624729.RA6ydFzsLQnZcoU7Fuiighs-R6VFzyesTC9gC5BUMdr9w130_provenance.
• NP1147101.RAEUWsJbT1aFxI3nHrBpLo89yIsmBxdJaZlTjYdkbNoGw130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147101.RAEUWsJbT1aFxI3nHrBpLo89yIsmBxdJaZlTjYdkbNoGw130_provenance.
• NP1147102.RAKJMXZsuRf3bDkrx_l4dkTuVA9WGCHIiqhIqqgUwAXrk130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147102.RAKJMXZsuRf3bDkrx_l4dkTuVA9WGCHIiqhIqqgUwAXrk130_provenance.
• NP1147109.RAJaDSP0Pgt3tIIuAf05Bp8UX6YFdwL8j6xduQtMi29QY130_assertion description "[Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation and may identify FoxO as a novel biomarker to stratify patients with RCC for PI3K or AKT inhibitor treatment, or a novel therapeutic target to synergize with PI3K-AKT inhibition in RCC treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147109.RAJaDSP0Pgt3tIIuAf05Bp8UX6YFdwL8j6xduQtMi29QY130_provenance.